Laurus Global Equity Management Inc. Has $2.64 Million Stock Position in Balchem Corporation (NASDAQ:BCPC)

Laurus Global Equity Management Inc. lowered its stake in Balchem Corporation (NASDAQ:BCPC - Free Report) by 16.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,920 shares of the basic materials company's stock after selling 3,170 shares during the period. Balchem makes up 1.8% of Laurus Global Equity Management Inc.'s holdings, making the stock its 15th biggest holding. Laurus Global Equity Management Inc.'s holdings in Balchem were worth $2,643,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Covestor Ltd lifted its stake in Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the period. Federated Hermes Inc. bought a new stake in Balchem during the fourth quarter worth $33,000. Versant Capital Management Inc grew its holdings in Balchem by 534.2% during the first quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock worth $40,000 after buying an additional 203 shares in the last quarter. Huntington National Bank grew its holdings in Balchem by 30.9% during the fourth quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock worth $108,000 after buying an additional 156 shares in the last quarter. Finally, Atala Financial Inc bought a new stake in Balchem during the fourth quarter worth $123,000. Institutional investors own 87.91% of the company's stock.

Balchem Trading Down 2.2%

BCPC opened at $158.44 on Friday. The stock has a market cap of $5.17 billion, a PE ratio of 38.00, a PEG ratio of 3.49 and a beta of 0.89. The company has a quick ratio of 1.40, a current ratio of 2.44 and a debt-to-equity ratio of 0.18. The business has a 50 day moving average of $163.82 and a 200-day moving average of $162.93. Balchem Corporation has a 52 week low of $145.70 and a 52 week high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The company had revenue of $250.52 million for the quarter, compared to analysts' expectations of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.03 EPS. Equities research analysts predict that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. HC Wainwright set a $180.00 price objective on Balchem and gave the stock a "buy" rating in a report on Monday, April 28th. Wall Street Zen cut Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.